Enteric fever, caused by Salmonella enterica serovars Typhi and Paratyphi, remains a significant global health concern. This article aims to provide a comprehensive guide to an integrated approach for its diagnosis and clinical management.
Diagnosing enteric fever involves isolating the bacteria from blood, bone marrow, or specific lesions. However, these methods can be time-consuming and lack sensitivity. Recent advances include molecular diagnostic techniques, such as polymerase chain reaction (PCR), which offer rapid and accurate identification. Serological tests, while less specific, can be useful in low-resource settings or when cultures are unavailable.
Antimicrobial therapy remains the cornerstone of enteric fever management. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. However, increasing antimicrobial resistance necessitates regular susceptibility testing and judicious use of antibiotics.
Supportive care plays a critical role in managing complications and improving patient outcomes. This includes hydration, nutritional support, and management of symptoms such as fever and pain. Close monitoring for potential complications, such as intestinal perforation or neurologic manifestations, is essential.
Vaccination is a crucial preventive measure, particularly in endemic regions. Two vaccines are currently available: the injectable Vi polysaccharide vaccine and the oral Ty21a vaccine. Both have demonstrated efficacy, although neither provides complete protection.
The management of enteric fever requires a comprehensive, integrated approach that considers accurate diagnosis, effective antimicrobial therapy, supportive care, and preventive measures such as vaccination. As the landscape of antimicrobial resistance evolves, ongoing research and development of new diagnostic methods, therapeutics, and vaccines will be crucial to maintaining progress against this global health threat.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation